APT: BiomX's Merger with Adaptive Phage Therapeutics
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the [...]
Read full article »
Interim-CEO
Ian Hardy
APT is a Maryland-based biotechnology company that researches and develops antimicrobial therapeutics to treat multidrug-resistant infections.
Read more